Ohio board rejects medical marijuana for autism

Cleveland.com highlights UC expert's testimony to State Medical Board

The State Medical Board of Ohio rejected proposals to add autism and female orgasmic difficulty disorder to the list of qualified conditions for which patients can obtain medical marijuana.

The decision came following testimony from experts including the University of Cincinnati's Craig Erickson, MD, associate professor in UC's College of Medicine and a Cincinnati Children's Hospital physician researcher, who spoke against the inclusion of autism on the approved conditions list.

Cleveland.com highlighted Erickson's and other experts' testimony in an article about the board's decision. Erickson told the board adults and children with autism are increasingly testing positive for THC even though there are not reports of clearly positive change in autism spectrum disorder patients.

Erickson added he's concerned that some patients are not capable of giving consent for cannabis, due to the communication deficits that are part of their autism spectrum disorder.

Read the Cleveland.com article.

Featured photo at top of marijuana leaves. Photo/Jeff W/Unsplash.

 

Related Stories

1984 Results
1

CCM welcomes new dance faculty member Hee Ra Yoo

July 22, 2025

UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of Hee Ra Yoo as CCM's new Assistant Professor of Dance. Her faculty appointment officially begins on Aug. 15, 2025. An international dance teacher and choreographer, Yoo founded the New York contemporary dance company “Yoo and Dancers.”

3

Jet engine-powered growth in southwest Ohio’s small towns

July 21, 2025

The Cincinnati Business Courier recently reported that manufacturing giant GE Aerospace plans to invest over $100 million into its southwest Ohio facilities this year. According to the Courier, the investment is likely to create new jobs and drive economic growth between Cincinnati and Dayton.

4

New global trial testing oral therapy for MS spasticity

July 21, 2025

The University of Cincinnati's Shahla Hosseini, MD, PhD, was featured in a Multiple Sclerosis News Today article discussing a new international clinical trial testing an oral drug that enhances naturally occurring molecules in the body to help muscles relax as a treatment for spasticity in patients with MS.